Anlotinib combined with etoposide for platinum-resistant recurrent ovarian cancer: A case report

INTRODUCTION: Platinum-resistant ovarian cancer is characterized by its poor prognosis and limited treatment options. Angiogenesis plays a fundamental role in the development of drug-resistance in ovarian cancer. Anlotinib, a novel oral multi-targeted tyrosine kinase inhibitor which targets a board...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Medicine (Baltimore)
Main Authors: Sun, Li, Yang, Meng, Zhang, Xuan, Li, Hua, Wu, Lingying, Zhang, Yuzi, Cai, Shangli
Format: Artigo
Sprog:Inglês
Udgivet: Wolters Kluwer Health 2020
Fag:
5600
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7253621/
https://ncbi.nlm.nih.gov/pubmed/32443311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000020053
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker